Cargando…

Impaired plasma lipid profiles in acute hepatitis

The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Libo, Pu, Xiangke, Wang, Yongzhong, Xu, Ning
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824760/
https://www.ncbi.nlm.nih.gov/pubmed/20096126
http://dx.doi.org/10.1186/1476-511X-9-5
_version_ 1782177735404158976
author Luo, Libo
Pu, Xiangke
Wang, Yongzhong
Xu, Ning
author_facet Luo, Libo
Pu, Xiangke
Wang, Yongzhong
Xu, Ning
author_sort Luo, Libo
collection PubMed
description The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), lipoprotein (a) (Lp(a)), blood coagulation status including prothrombin complex activity and activated partial tromboplastin time (APTT), and hepatic functions were determined by the automatic biochemical analytical instrument. It demonstrated that plasma levels of total cholesterol, HDL-C and apoAI were significantly lower in the patients at the acute phase of hepatitis than those in normal subjects, whereas plasma levels of TG and LDL-C were obviously higher in the patients than in normal subjects (P < 0.05). Moreover, we demonstrated that patients' plasma levels of total cholesterol, LDL-C, HDL-C and apoAI were lower at the active phase of the diseases than at the recovering phase, which indicating that acute liver damage could significant influence lipid metabolism in vivo. No pathological changes of blood coagulation status occurred in these patients during the study as all selected patients had moderate hepatitis. It may conclude that examinations of plasma lipid profile could be considered as a clinical index to reflect liver damage in the active phase of hepatitis.
format Text
id pubmed-2824760
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28247602010-02-20 Impaired plasma lipid profiles in acute hepatitis Luo, Libo Pu, Xiangke Wang, Yongzhong Xu, Ning Lipids Health Dis Research The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), lipoprotein (a) (Lp(a)), blood coagulation status including prothrombin complex activity and activated partial tromboplastin time (APTT), and hepatic functions were determined by the automatic biochemical analytical instrument. It demonstrated that plasma levels of total cholesterol, HDL-C and apoAI were significantly lower in the patients at the acute phase of hepatitis than those in normal subjects, whereas plasma levels of TG and LDL-C were obviously higher in the patients than in normal subjects (P < 0.05). Moreover, we demonstrated that patients' plasma levels of total cholesterol, LDL-C, HDL-C and apoAI were lower at the active phase of the diseases than at the recovering phase, which indicating that acute liver damage could significant influence lipid metabolism in vivo. No pathological changes of blood coagulation status occurred in these patients during the study as all selected patients had moderate hepatitis. It may conclude that examinations of plasma lipid profile could be considered as a clinical index to reflect liver damage in the active phase of hepatitis. BioMed Central 2010-01-23 /pmc/articles/PMC2824760/ /pubmed/20096126 http://dx.doi.org/10.1186/1476-511X-9-5 Text en Copyright ©2010 Luo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Luo, Libo
Pu, Xiangke
Wang, Yongzhong
Xu, Ning
Impaired plasma lipid profiles in acute hepatitis
title Impaired plasma lipid profiles in acute hepatitis
title_full Impaired plasma lipid profiles in acute hepatitis
title_fullStr Impaired plasma lipid profiles in acute hepatitis
title_full_unstemmed Impaired plasma lipid profiles in acute hepatitis
title_short Impaired plasma lipid profiles in acute hepatitis
title_sort impaired plasma lipid profiles in acute hepatitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824760/
https://www.ncbi.nlm.nih.gov/pubmed/20096126
http://dx.doi.org/10.1186/1476-511X-9-5
work_keys_str_mv AT luolibo impairedplasmalipidprofilesinacutehepatitis
AT puxiangke impairedplasmalipidprofilesinacutehepatitis
AT wangyongzhong impairedplasmalipidprofilesinacutehepatitis
AT xuning impairedplasmalipidprofilesinacutehepatitis